Ixabepilone (Ixempra)
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Ixabepilone (Ixempra), covering 2011-04-04 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP. [Phase 2]